PeptAI is an autonomous AI agent that discovers new peptide drug candidates.
Tackling aging with the power of a global community and radically extend healthy human lifespan by funding cutting-edge aging research and democratizing ownership of Intellectual Property.
CryoDAO's objective is to contribute to cryopreservation research projects that have a high potential to increase the quality and capabilities of cryopreservation.
eDMT Commons enables shared governance over multiple R&D efforts into how the brain regulates its own DMT.
Curing the 10,000 rare genetic diseases.
Peptai
VitaDAO
CryoDAO
eDMT Commons
Curetopia
21.50%
